Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis - PubMed (original) (raw)
Affiliations
- PMID: 12508387
Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis
Frederick Wolfe et al. J Rheumatol. 2003 Jan.
Abstract
Objective: To determine whether the risk for cardiovascular and/or cerebrovascular disease (CCVD) is increased in rheumatoid arthritis (RA) compared to osteoarthritis (OA), a disease not known to be associated with increased CCVD.
Methods: In July 1999, a survey was administered to a sample of 11,572 patients (9,093 with RA, 2479 with OA) from the practices of 709 US community-based rheumatologists. Patients reported past and current myocardial infarction (MI), stroke (cerebrovascular accident, CVA), and lifetime congestive heart failure (CHF), and also provided demographic and clinical information. To estimate the impact of recall bias, medical records were obtained and reviewed for a 50% random sample of the patients reporting CCVD events, with 95% of CCVD reported events confirmed by record review.
Results: Patients with RA and OA differed across all demographic variables. In addition, each variable was significantly associated with MI, CHF, and CVA outcomes. Logistic regression was performed to measure the associations of these outcomes with RA as compared to OA, adjusting for age, sex, education level, smoking, income, hypertension, and body mass index. Compared with OA, patients with RA had the following increased risks: for current MI [odds ratio (OR), 95% confidence interval (95% CI)] 2.14, (1.48, 3.09), lifetime MI 1.28 (1.24, 1.33), CHF 1.43 (1.28, 1.59), current CVA 1.70 (1.29, 2.24), and lifetime CVA 1.005 (0.931, 1.196). The adjusted current and lifetime prevalences of MI were 0.76 and 4.14% for RA versus 0.35 and 3.23% respectively for OA; 0.86 and 3.02% (RA) versus 0.50 and 3.03% (OA) for CVA; and for lifetime CHF, 2.34% (RA) versus 1.64% (OA), respectively.
Conclusions: RA is associated with an increased risk for CCVD morbidity due to MI, CHF, and probably for CVA, and may be an independent risk factor for these events.
Similar articles
- Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study.
Maradit-Kremers H, Crowson CS, Nicola PJ, Ballman KV, Roger VL, Jacobsen SJ, Gabriel SE. Maradit-Kremers H, et al. Arthritis Rheum. 2005 Feb;52(2):402-11. doi: 10.1002/art.20853. Arthritis Rheum. 2005. PMID: 15693010 Review. - Consequences of increased systolic blood pressure in patients with osteoarthritis and rheumatoid arthritis.
Singh G, Miller JD, Huse DM, Pettitt D, D'Agostino RB, Russell MW. Singh G, et al. J Rheumatol. 2003 Apr;30(4):714-9. J Rheumatol. 2003. PMID: 12672188 - Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients?
Gonzalez A, Maradit Kremers H, Crowson CS, Ballman KV, Roger VL, Jacobsen SJ, O'Fallon WM, Gabriel SE. Gonzalez A, et al. Ann Rheum Dis. 2008 Jan;67(1):64-9. doi: 10.1136/ard.2006.059980. Epub 2007 May 21. Ann Rheum Dis. 2008. PMID: 17517756 - Incident myocardial infarction associated with major types of arthritis in the general population: a systematic review and meta-analysis.
Schieir O, Tosevski C, Glazier RH, Hogg-Johnson S, Badley EM. Schieir O, et al. Ann Rheum Dis. 2017 Aug;76(8):1396-1404. doi: 10.1136/annrheumdis-2016-210275. Epub 2017 Feb 20. Ann Rheum Dis. 2017. PMID: 28219882 Review.
Cited by
- A bibliometric analysis of income and cardiovascular disease: Status, Hotspots, Trends and Outlook.
Ding Y, Chen D, Ding X, Wang G, Wan Y, Shen Q. Ding Y, et al. Medicine (Baltimore). 2020 Aug 21;99(34):e21828. doi: 10.1097/MD.0000000000021828. Medicine (Baltimore). 2020. PMID: 32846827 Free PMC article. Review. - Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis.
Dessein PH, Joffe BI, Singh S. Dessein PH, et al. Arthritis Res Ther. 2005;7(3):R634-43. doi: 10.1186/ar1717. Epub 2005 Mar 24. Arthritis Res Ther. 2005. PMID: 15899050 Free PMC article. - Immunoglobulin A anti-phospholipid antibodies in Swedish cases of systemic lupus erythematosus: associations with disease phenotypes, vascular events and damage accrual.
Frodlund M, Vikerfors A, Grosso G, Skogh T, Wetterö J, Elvin K, Gunnarsson I, Kastbom A, Dahlström Ö, Rönnelid J, Svenungsson E, Sjöwall C. Frodlund M, et al. Clin Exp Immunol. 2018 Oct;194(1):27-38. doi: 10.1111/cei.13180. Epub 2018 Sep 12. Clin Exp Immunol. 2018. PMID: 30208508 Free PMC article. - Serum oxidized low-density lipoproteins in rheumatoid arthritis.
Kim SH, Lee CK, Lee EY, Park SY, Cho YS, Yoo B, Moon HB. Kim SH, et al. Rheumatol Int. 2004 Jul;24(4):230-3. doi: 10.1007/s00296-003-0358-4. Epub 2003 Nov 20. Rheumatol Int. 2004. PMID: 14628150 - Plasma from Patients with Rheumatoid Arthritis Reduces Nitric Oxide Synthesis and Induces Reactive Oxygen Species in A Cell-Based Biosensor.
Herlitz-Cifuentes H, Vejar C, Flores A, Jara P, Bustos P, Castro I, Poblete E, Saez K, Opazo M, Gajardo J, Aguayo C, Nova-Lamperti E, Lamperti L. Herlitz-Cifuentes H, et al. Biosensors (Basel). 2019 Feb 27;9(1):32. doi: 10.3390/bios9010032. Biosensors (Basel). 2019. PMID: 30818887 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous